NYSEARCA:IHE iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News $176.98 -1.28 (-0.72%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$176.76▼$179.0750-Day Range$176.91▼$191.3852-Week Range$166.99▼$191.74Volume5,794 shsAverage Volume8,167 shsMarket Capitalization$362.81 millionAssets Under Management$353.91 millionDividend Yield2.11%Net Expense Ratio0.39% ProfileProfileChartHeadlinesHoldingsOptions ChainRatingsProfileChartHeadlinesHoldingsOptions ChainRatings About iShares U.S. Pharmaceuticals ETFiShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors.Read More IHE Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IHE ETF News HeadlinesAugust 21, 2023 | msn.comIHE: A Highly Concentrated Portfolio Is Able To Generate Growth Over The Long RunAugust 15, 2023 | finance.yahoo.comThe Zacks Analyst Blog Highlights URNJ, IHE and PXEOctober 1, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...August 15, 2023 | msn.comPharma ETF (IHE) Hit a 52-Week HighAugust 11, 2023 | msn.comSupreme Court Halts Purdue Pharma's $6B Settlement: Sackler Family's Shield From Opioid Lawsuits ChallengedJune 7, 2023 | seekingalpha.comiShares U.S. Pharmaceuticals ETF declares quarterly distribution of $0.5903June 6, 2023 | msn.com3 Biotech Stocks to Sell in June Before They Crash and BurnMay 9, 2023 | msn.comPharma ETFs Gain Post Q1 EarningsOctober 1, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.March 31, 2023 | fool.comHow to Invest in Johnson & Johnson StockSee More Headlines Receive IHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares U.S. Pharmaceuticals ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IHE Inception Date5/1/2006 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason Webwww.iShares.com PhoneN/AFund Focus Asset ClassEquity BenchmarkDow Jones U.S. Select Pharmaceuticals Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings38 Fund Statistics Assets Under Management$353.91 million Average Daily Volume$19,287.40 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorCitibank, N.A. AdvisorBlackRock Fund Advisors CustodianCitibank, N.A. DistributorBlackRock Investments, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableN/A Short Interest13,200 shs Miscellaneous Outstanding Shares2,050,000Beta0.70 Creation Unit50,000 Creation Fee$306.00 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report iShares U.S. Pharmaceuticals ETF ExpensesTypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.39%0.57%0.53%0.50%0.50%Other Expenses0.00%0.40%0.52%0.64%0.57%Total Expense0.39%0.72%0.69%0.74%0.69%Fee Waiver0.00%-0.51%-0.55%-0.70%-0.59%Net Expense0.39%0.61%0.59%0.57%0.57% iShares U.S. Pharmaceuticals ETF (IHE) Holdings & ExposureTop 10 IHE HoldingsEli Lilly and Company(NYSE:LLY)Holding Weight: 24.95%Johnson & Johnson(NYSE:JNJ)Holding Weight: 22.68%Zoetis(NYSE:ZTS)Holding Weight: 4.83%Viatris(NASDAQ:VTRS)Holding Weight: 4.74%Merck & Co., Inc.(NYSE:MRK)Holding Weight: 4.06%Bristol-Myers Squibb(NYSE:BMY)Holding Weight: 3.93%Pfizer(NYSE:PFE)Holding Weight: 3.84%Royalty Pharma(NASDAQ:RPRX)Holding Weight: 3.78%Jazz Pharmaceuticals(NASDAQ:JAZZ)Holding Weight: 3.06%Catalent(NYSE:CTLT)Holding Weight: 2.95%IHE Sector ExposureIHE Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D. (Age 78)Independent Chairman of the Board of Trustees Michael Arthur Latham (Age 51)President, Trustee Jack Gee (Age 57)Chief Financial Officer, Treasurer Geoffrey D. FlynnChief Operating Officer, Executive Vice PresidentAmy Schioldager (Age 56)Executive Vice President Ira P. Shapiro (Age 52)Vice President, Chief Legal Officer Matt TuckerVice PresidentEilleen M. Clavere (Age 61)Secretary Cecilia H. Herbert (Age 68)Independent Trustee Charles A. Hurty (Age 73)Independent Trustee More ExecutivesSimilar ETFsSPDR S&P Health Care Equipment ETFNYSEARCA:XHEVanEck Pharmaceutical ETFNASDAQ:PPHVanEck Biotech ETFNASDAQ:BBHInvesco Pharmaceuticals ETFNYSEARCA:PJPInvesco Biotechnology & Genome ETFNYSEARCA:PBEInstitutional OwnershipOsaic Holdings Inc.Bought 77 shares on 8/21/2023Ownership: 0.535%Goldman Sachs Group Inc.Sold 53 shares on 8/15/2023Ownership: 1.062%Beacon Pointe Advisors LLCSold 70 shares on 8/15/2023Ownership: 0.310%Integrated Wealth Concepts LLCSold 529 shares on 8/15/2023Ownership: 0.224%Stifel Financial CorpSold 362 shares on 8/15/2023Ownership: 0.110%View All Institutional Transactions IHE ETF - Frequently Asked Questions How have IHE shares performed in 2023? iShares U.S. Pharmaceuticals ETF's stock was trading at $186.13 at the beginning of 2023. Since then, IHE stock has decreased by 4.9% and is now trading at $176.9808. View the best growth stocks for 2023 here. What does IHE invest in? iShares U.S. Pharmaceuticals ETF is a equity fund issued by iShares. IHE focuses on health care investments and follows the Dow Jones U.S. Select Pharmaceuticals Index. The fund's investments total to approximately $353.91 million assets under management. What stocks does iShares U.S. Pharmaceuticals ETF hold? IHE invests in 38 holdings. Some of the stocks in their portfolio include Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Zoetis (ZTS), Viatris (VTRS), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Pfizer (PFE), Royalty Pharma (RPRX), Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). What is the management fee for iShares U.S. Pharmaceuticals ETF? iShares U.S. Pharmaceuticals ETF's management fee is 0.39% and has no other recorded expenses or fee waivers. The net expense ratio for IHE is 0.39%. What other stocks do shareholders of iShares U.S. Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares U.S. Pharmaceuticals ETF investors own include United Parcel Service (UPS), CVS Health (CVS), Genuine Parts (GPC), Intel (INTC), Kinder Morgan (KMI), Wells Fargo & Company (WFC), Archer-Daniels-Midland (ADM), BP (BP) and Campbell Soup (CPB). What is iShares U.S. Pharmaceuticals ETF's stock symbol? iShares U.S. Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IHE." How do I buy shares of iShares U.S. Pharmaceuticals ETF? Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iShares U.S. Pharmaceuticals ETF's stock price today? One share of IHE stock can currently be purchased for approximately $176.98. How much money does iShares U.S. Pharmaceuticals ETF make? iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) has a market capitalization of $362.81 million. This page (NYSEARCA:IHE) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.